Dr. Ohnsman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
115 Grandview Blvd
Reading, PA 19609Phone+1 610-914-2718
Summary
- After over 20 years as a practicing pediatric ophthalmologist, I am now a medical writer and consultant with expertise in ophthalmology, gene therapy, and rare and orphan diseases. As president of CMO Medical Communications, LLC, I remain dedicated to my consistent, passionate focus on improving patients’ lives.
Education & Training
- Children's Hospital Medical Center of Akron/NEOMEDFellowship, Pediatric Ophthalmology, 1993 - 1994
- University of Cincinnati Medical Center/College of MedicineResidency, Ophthalmology, 1990 - 1993
- Atlantic Health System/Morristown Medical CenterInternship, Internal Medicine, 1989 - 1990
- Rutgers New Jersey Medical SchoolClass of 1989
Certifications & Licensure
- PA State Medical License 1994 - 2024
- OH State Medical License 1990 - 1994
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 1 citationsOCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy.Wei Chieh Huang, Christina M Ohnsman, Yevgeniya Atiskova, Paulo Falabella, Martin S Spitzer
Investigative Ophthalmology & Visual Science. 2024-07-01 - Laboratory data and statistical evidence in fluoroquinolone study.Richard J. O'Callaghan, Christina Ohnsman, Jenny Song
Journal of Cataract and Refractive Surgery. 2008-10-01 - 22 citationsComparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitisChristina M Ohnsman, David C. Ritterband, Terrence P. O'Brien, Dalia Girgis, Al Kabat
Current Medical Research and Opinion. 2007-08-08
Journal Articles
- Brave New World: Gene Therapy for Inherited Retinal DiseaseLeroy BP, Pennesi ME, Ohnsman, CM, EyeNet, 7/1/2018
Books/Book Chapters
Abstracts/Posters
- RPE65 Mutation Subtype Effect on Baseline Visual Function and Treatment Response in Phase 3 Voretigene Neparvovec TrialMahajan VB, Bennett J, Maguire A, Haller J, Leroy BP, Sohn EH, Drack A, Ohnsman CM, Ciulla T, Chung D, High KA, Annual Meeting of the American Academy of Ophthalmology, Chicago, IL, 10/27/2018
Other
- Recognizing and Treating Serious Cases of ConjunctivitisDorfman, MS and Ohnsman, CM, Medscape
https://www.medscape.org/viewarticle/723969
6/24/2010 - Pediatric bacterial conjunctivitis: Identification, prevention, and treatmentDorfman, MS and Ohnsman, CM, Medscape
http://cme.medscape.com/viewprogram/30398
7/17/2009
Authored Content
- Rare Diseases Aren't That RareFebruary 2019
- Rare Diseases Aren't That RareFebruary 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: